Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "Niczyporuk, A." wg kryterium: Autor


Wyświetlanie 1-5 z 5
Tytuł:
Phytochemical screening of Pulsatilla species and investigation of their biological activities
Autorzy:
Laska, G.
Sienkiewicz, A.
Stocki, M.
Zjawiony, J.K.
Sharma, V.
Bajguz, A.
Piotrowska-Niczyporuk, A.
Jacob, M.
Khan, S.
Powiązania:
https://bibliotekanauki.pl/articles/56981.pdf
Data publikacji:
2019
Wydawca:
Polskie Towarzystwo Botaniczne
Opis:
The present study aimed to identify biologically active secondary metabolites from the rare plant species, Pulsatilla patens subsp. patens and the cultivated P. vulgaris subsp. vulgaris. Chromatographic fractionation of the ethanolic extract of the roots of P. patens subsp. patens resulted in the isolation of two oleanane-type glycosides identified as hederagenin 3-O-β-d-glucopyranoside (2.7 mg) and hederagenin 3-O-β-d-galactopyranosyl-(1→2)-β-d-glucopyranoside (3.3 mg, patensin). HPLC analysis of the methanolic extract of the crude root of P. patens subsp. patens and P. vulgaris subsp. vulgaris revealed the presence of Pulsatilla saponin D (hederagenin 3-O-α-l-rhamnopyranosyl(1→2)-[β-d-glucopyranosyl(1→4)]-α-l-arabinopyranoside). Chromatographic analysis using GC-MS of the silylated methanolic extracts from the leaves and roots of these species identified the presence of carboxylic acids, such as benzoic, caffeic, malic, and succinic acids. The extracts from Pulsatilla species were tested for their antifungal, antimicrobial, and antimalarial activities, and cytotoxicity to mammalian cell lines. Both P. patens subsp. patens and P. vulgaris subsp. vulgaris were active against the fungus Candida glabrata with the half-maximal inhibitory concentration (IC₅₀) values of 9.37 μg/mL and 11 μg/mL, respectively. The IC₅₀ values for cytotoxicity evaluation were in the range of 32–38 μg/mL for P. patens subsp. patens and 35–57 μg/mL for P. vulgaris subsp. vulgaris for each cell line, indicating general cytotoxic activity throughout the panel of evaluated cancer and noncancer cells.
Źródło:
Acta Societatis Botanicorum Poloniae; 2019, 88, 1
0001-6977
2083-9480
Pojawia się w:
Acta Societatis Botanicorum Poloniae
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Evaluation of the quality of life of patients with osteoarthritis
Autorzy:
Niczyporuk, M.
Kłossowska, J.
Kleszczewska, E.
Shpakou, A.
Knaś, M.
Powiązania:
https://bibliotekanauki.pl/articles/1918782.pdf
Data publikacji:
2018
Wydawca:
Uniwersytet Medyczny w Białymstoku
Tematy:
uality of life
osteoarthritis
chronic diseas
Opis:
Purpose: The tools for measuring objective quality of life include research regarding the conditions of a successful life and life satisfaction. Osteoarthritis (OA) is characterized by progressive degradation and loss of articular cartilage as well as abnormal bone growth and remodeling, located directly under the cartilage. The aim of this study is to answer the question on which level OA patients perceive their quality of life dependent on health. Material and methods: The Polish version of the HAQ questionnaire, assessing the quality of life over the past week, was used for overall assessment of quality of life. The Polish version of the AIMS-2 questionnaire was used as a specific questionnaire for assessing the health status of patients with osteoarthritis. Surveys were conducted in a group of 240 people. Results: The quality of life dependent on health is significantly reduced in the group of healthy people who take painkillers sporadically because of other reasons and in the OA pateints group compared to the control group, the same as in the OA pateints group compared to the group of healthy people who take painkillers sporadically for other reasons. Conclusions: According to the answers from the questionnaire, patients with OA seek different forms of improving their quality of life. It is important to change their lifestyle (weight reduction, using a bench-mounted bike, walking stick or walking frame), reducing the surface area of the joints, reducing the defective position of the limb axis. Exercises that increase muscle mass and exercises to improve joint mobility should be introduced. It is advisable to refer the OA patient for physical therapy and/or balneotherapy.
Źródło:
Progress in Health Sciences; 2018, 8(2); 1-9
2083-1617
Pojawia się w:
Progress in Health Sciences
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Quality of life of osteoarthritis patients in the aspect of analgesic treatment
Autorzy:
Niczyporuk, M.
Kłossowska, J.
Kleszczewska, E.
Shpakou, A.
Knaś, M.
Powiązania:
https://bibliotekanauki.pl/articles/1918857.pdf
Data publikacji:
2019-08-26
Wydawca:
Uniwersytet Medyczny w Białymstoku
Tematy:
Osteoarthritis
analgesics
quality of life
Opis:
Introduction: Osteoarthritis an inflammatory process in the synovial membrane. These changes cause pain and joint deformities. Pharmacists can assess patients’ quality of life, which can be a good criterion for assessing analgesics treatment effectiveness and prevent the growing phenomenon of polypharmacy and self-treatment. Purpose: To answer these questions: 1) Is there a relationship between the quality of life of patients with osteoarthritis taking analgesics and those with osteoarthritis taking analgesics and implemented rehabilitation? 2) Do patients using analgesics practice polypharmacy? 3) Are patients with osteoarthritis the main consumers of painkillers? and 4) Does the use of analgesics affect the health-related quality of life of patients with osteoarthritis? Materials and methods: The study was conducted on 240 people who were divided into three groups: osteoarthritis, reference (generally healthy, occasionally taking analgesics), and control (generally healthy, no intake of analgesics). To assess the rise in analgesics consumption by patients with osteoarthritis and the phenomenon of polypharmacy, an original questionnaire was used. Results: There is a relationship between the quality of life of patients with osteoarthritis taking analgesics. Statistical analysis showed that in the years 2013-2015 the purchase of prescription analgesics and without a prescription systematically, significantly increased. Conclusions: Patients using analgesics unknowingly practice polypharmacy. In Ars Medica Pharmacies, analgesics purchases by patients with osteoarthritis grew significantly in the analyzed period, but they are not the main analgesics consumers. Use of analgesics by patients with osteoarthritis improves their health-related quality of life.
Źródło:
Progress in Health Sciences; 2019, 1; 36-44
2083-1617
Pojawia się w:
Progress in Health Sciences
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Prevalence and selected determinants of the risk of problem gambling among Polish secondary school students
Autorzy:
Niewiadomska, I.
Panasiuk, L.
Chwaszcz, J.
Furtak-Niczyporuk, M.
Dreher, P.
Zygo, K.
Jaroszyński, J.
Mela, A.
Powiązania:
https://bibliotekanauki.pl/articles/28762887.pdf
Data publikacji:
2020
Wydawca:
Instytut Medycyny Wsi
Źródło:
Annals of Agricultural and Environmental Medicine; 2020, 27, 4; 650-656
1232-1966
Pojawia się w:
Annals of Agricultural and Environmental Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
OFF-LABEL USE OF MEDICINAL PRODUCTS - LEGAL RULES AND PRACTICES
Autorzy:
Jaroszyński, Janusz
Mela, Aneta
Furtak-Niczyporuk, Marzena
Staniszewska, Anna
Poniatowski, Łukasz A.
Dąbrowski, Jan
Czajka-Bełz, Anna
Zimmermann, Agnieszka
Dreher, Piotr
Drop, Bartłomiej
Powiązania:
https://bibliotekanauki.pl/articles/895505.pdf
Data publikacji:
2019-08-30
Wydawca:
Polskie Towarzystwo Farmaceutyczne
Tematy:
health policy
pharmaceuticals
medicinal products
off-label drug use
prescribing
Opis:
The off-label use of medicinal products raises many interpretation-related issues, not only among physicians, but also pharmacists and lawyers. The use of drugs in a manner other than that specified in the Summary of Product Characteristics is not regulated by Polish law. The authors’ goal is to discuss the topic mainly from the practical perspective, while also considering its theoretical aspects, and to identify systemic solutions to several problems, that are extremely important for the proper functioning of the entire healthcare system. The paper highlights that there is a fine line between experimental medicinal practices and those that are in keeping with current medical knowledge.
Źródło:
Acta Poloniae Pharmaceutica - Drug Research; 2019, 76, 4; 621-628
0001-6837
2353-5288
Pojawia się w:
Acta Poloniae Pharmaceutica - Drug Research
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies